Qube Research & Technologies LTD Compass Therapeutics, Inc. Transaction History

Qube Research & Technologies LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$3.14 - $5.48 $312,835 - $545,966	99,629 Added 158.15%	162,624 $531,000
Q4 2022 Feb 14, 2023	BUY	$2.55 - $5.41 $160,637 - $340,802	62,995 New	62,995 $316,000
Q2 2022 Aug 15, 2022	SELL	$1.43 - $3.1 $75,564 - $163,810	-52,842 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$1.25 - $3.5 $29,736 - $83,261	23,789 Added 81.88%	52,842 $72,000
Q4 2021 Feb 01, 2022	BUY	$2.88 - $3.98 $83,672 - $115,630	29,053 New	29,053 $92,000

91.9M

Ticker CMPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 101,285,000
Market Cap $139M
Description
Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.